CClinicalTrials.gg
Active, not recruitingNCT04985279Updated Aug 7, 2026

Position and Angle Marking System (PAMS) for Ultrasound-guided Neuraxial Procedures

An interventional study of Position and Angle Marking System and Standard clinical practice in Ultrasound-guided Neuraxial Procedures, sponsored by KK Women's and Children's Hospital. Active, not recruiting at 1 site in Singapore. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-07.

Sponsored by KK Women's and Children's Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Epidural anaesthesia involves the administration of numbing medication (local anaesthetics) close to the spinal canal, and is regarded as the best method for providing pain relief during labour and childbirth. The use of ultrasound to guide epidural insertion and placement has been shown to improve pain relief and reduce the risk of complications.

However, after identifying the desired needle insertion site via ultrasound, current practice involves demarcating the insertion site using marker pens, which is time-consuming, inaccurate, and may be inadvertently removed by skin sterilisation. Furthermore, the desired needle angulation determined by ultrasound cannot be accurately measured and maintained during the epidural procedure. Both issues limit the benefits of using ultrasound to guide the epidural procedure.

To address these issues, the investigators developed a Position and Angular Marking System (PAMS) that attaches on to the ultrasound probe. When the desired insertion site is identified by ultrasound, the doctor gently presses PAMS into the patient's back to create skin indentations demarcating the needle insertion point. These indentations are not affected by skin sterilisation, and may improve accuracy and reduce the time taken to perform the epidural procedure. Next, the angle between the ultrasound probe and the patient's back can be measured using PAMS, and this angle can be maintained using a needle guide during the epidural procedure.

The purpose of this randomised study is to evaluate the usability of PAMS and to identify areas for further improvement.

This study will involve up to 10 healthy simulated patients, and up to 30 volunteer ultrasound operators. After undergoing a standardised training session with a mannequin, the ultrasound operators will be randomly assigned to perform skin marking on the simulated patients as though they are performing an ultrasound-guided epidural anaesthesia procedure (no needle puncture will be made) using either PAMS, or standard clinical practice with marker pens. After completing the procedure, the ultrasound operators will cross over and perform the procedure again using either PAMS or standard clinical practice with marker pens.

Both the ultrasound operators and simulated patients will be asked to complete satisfaction and usability surveys regarding their experience with the procedures.

Read the detailed description

The volunteer ultrasound operators are women's anaesthesiologists trained in the use of ultrasound-guided neuraxial procedures.

Simulated patients are healthy volunteers from other departments, without spine abnormalities.

The ultrasound operators will be asked to complete a questionnaire regarding your prior experience with neuraxial ultrasonography and undergo structured training on the use of PAMS using a mannequin. Next, they will be asked to perform the following two procedures (the order at which they will perform the procedures will be randomised):

  1. Ultrasound scan using PAMS

    • After attaching PAMS to the ultrasound probe, they will perform a lumbar ultrasound scan on a simulated patient to identify the desired needle insertion site and gently press PAMS into the simulated patient's back to create skin indentations demarcating the desired needle insertion site.
    • Next, adjust the angulation of the ultrasound probe to optimise the image of the simulated patient's lumbar spine, and read the angle between the ultrasound probe and patient's back off a graduated scale.
    • Remove the ultrasound probe, and position the needle-insertion guide corresponding to the skin indentations. Needle angulation can be simulated by mounting a blunt needle on to the insertion guide.
    • Finally, they will be asked to complete a usability questionnaire.
  2. Ultrasound scan without PAMS (standard clinical practice)

    • Perform a lumbar ultrasound scan to identify the desired needle insertion site, followed by demarcation using skin markers.
    • Next, adjust the angulation of the ultrasound probe to optimise the image of the simulated patient's lumbar spine.
    • Remove the ultrasound probe and simulate needle insertion by touching the tip of a blunt needle to the patient's back, at the desired angle.
    • Finally, they will then be asked to complete a usability questionnaire.

Both procedures are non-invasive (i.e. no skin punctures will be made). No follow up is required for this study.

No new research medications are involved in this study.

Additionally, video recordings may be made of the procedures. Any video or ultrasound images obtained during the course of this study will be stored and analysed only for the purposes of this study for a period not exceeding 7 years, and will be destroyed after completion of the study. Technical data such as the scanning duration and success rate will also be documented.

02

Conditions studied

  • Ultrasound-guided Neuraxial Procedures

Keywords

  • Ultrasonography
  • Epidural
  • Spinal
  • Labour analgesia
03

In context

Lead sponsor

KK Women's and Children's Hospital is the lead sponsor of 136 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Ultrasound operators

Inclusion Criteria:

  • Anaesthesiologists
  • Trained in the use of ultrasound-guided neuraxial procedures

Exclusion Criteria:

  • No experience with ultrasound-guided neuraxial procedures

Simulated patients

Inclusion Criteria:

  • Healthy, no significant medical comorbidity (American Society of Anesthesiologists Physical Status I or II)
  • No spinal abnormalities, or previous spinal surgery

Exclusion Criteria:

  • Significant spinal abnormality
  • Previous spinal surgery
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    Standard clinical practice

    * Lumbar ultrasound scan will be performed to identify the desired needle insertion site, followed by demarcation using skin markers. * The angulation of the ultrasound probe will be adjusted to optimise the image of the simulated patient's lumbar spine. * The ultrasound probe will be removed and needle insertion simulated by touching the tip of a blunt needle to the patient's back, at the desired angle. * A usability questionnaire regarding the procedure will be completed.

    Device: Standard clinical practice

  • Experimental
    Position and Angle Marking System (PAMS)

    * PAMS will be attached to the ultrasound probe. * Lumbar ultrasound scan will be performed to identify the desired needle insertion site, followed by demarcation by gentle pressing PAMS into the simulated patient's back to create skin indentations. * The angulation of the ultrasound probe will be adjusted to optimise the image of the simulated patient's lumbar spine, and the angle read off a graduated scale. * The ultrasound probe will be removed and needle insertion simulated by touching the tip of a blunt needle to the patient's back, at the desired angle. * A usability questionnaire regarding the procedure will be completed.

    Device: Position and Angle Marking System

Interventions

  • DevicePosition and Angle Marking System

    Position and Angular Marking System (PAMS) attaches on to the ultrasound probe. When the desired insertion site is identified by ultrasound, the doctor gently presses PAMS into the patient's back to create skin indentations demarcating the needle insertion point. These indentations are not affected by skin sterilisation, and may improve accuracy and reduce the time taken to perform the epidural procedure. Next, the angle between the ultrasound probe and the patient's back can be measured using PAMS, and this angle can be maintained using a needle guide during the epidural procedure.

    Also known as: PAMS

  • DeviceStandard clinical practice

    When the desired insertion site is identified by ultrasound, the doctor demarcate the needle insertion point using marker pens.

06

What researchers measure

Primary outcomes

  1. Satisfaction survey of simulated patients and operators

    Satisfaction and feedback regarding the respective procedures

    Time frame: Immediately after performing the procedure

Secondary outcomes

  1. Time taken to perform procedure

    Comparison of time taken to perform the interventional procedure (PAMS), versus standard clinical practice (control)

    Time frame: Immediately after performing the procedure

07

Study locations

1 site
  • KK Women's and Children's Hospital
    Singapore, 128038, Singapore
08

References and documents

Publications

  • Tan HS, Sng BL, Sia ATH. Reducing breakthrough pain during labour epidural analgesia: an update. Curr Opin Anaesthesiol. 2019 Jun;32(3):307-314. doi: 10.1097/ACO.0000000000000713. PubMed 31045638 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04985279
Lead sponsor
KK Women's and Children's Hospital
Responsible party
Sng Ban Leong (Senior Consultant, KK Women's and Children's Hospital) — Principal investigator
First posted
Aug 2, 2021
Start date
Sep 7, 2021
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Aug 7, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion